Selected research
Market Structure
Global Portable Bioimpedance Analyzer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Portable Bioimpedance Analyzer market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Portable Bioimpedance Analyzer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Portable Bioimpedance Analyzer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Portable Bioimpedance Analyzer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Portable Bioimpedance Analyzer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Portable Bioimpedance Analyzer include Emtesys, Omron Healthcare USA, AVANUTRI, LAICA International Corporation, Tanita, Diagnosis, Terraillon, Withings and iHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Portable Bioimpedance Analyzer market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Portable Bioimpedance Analyzer and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Portable Bioimpedance Analyzer sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Portable Bioimpedance Analyzer market size, projected growth trends, production technologies, key applications, and end-use industries.
Portable Bioimpedance Analyzer Segment by Company
Emtesys
Omron Healthcare USA
AVANUTRI
LAICA International Corporation
Tanita
Diagnosis
Terraillon
Withings
iHealth
Microlife
Bodivis
Fitbit
Medeia
InBody
Etekcity
Vitafit
FitTrack Dara
RJL Systems
Portable Bioimpedance Analyzer Segment by Type
Maximum Load Capacity 150kg
Maximum Load Capacity 180kg
Maximum Load Capacity 135kg
Other
Portable Bioimpedance Analyzer Segment by Application
Hospital
Weight Loss Agencies
Family
Other
Portable Bioimpedance Analyzer Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Portable Bioimpedance Analyzer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Portable Bioimpedance Analyzer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Portable Bioimpedance Analyzer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Portable Bioimpedance Analyzer market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Portable Bioimpedance Analyzer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Portable Bioimpedance Analyzer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Portable Bioimpedance Analyzer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Maximum Load Capacity 150kg
- Maximum Load Capacity 180kg
- Maximum Load Capacity 135kg
- Other
Applications
- Hospital
- Weight Loss Agencies
- Family
- Other
Companies covered
- Emtesys
- Omron Healthcare USA
- AVANUTRI
- LAICA International Corporation
- Tanita
- Diagnosis
- Terraillon
- Withings
- iHealth
- Microlife
- Bodivis
- Fitbit
- Medeia
- InBody
- Etekcity
- Vitafit
- FitTrack Dara
- RJL Systems
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Portable Bioimpedance Analyzer Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Portable Bioimpedance Analyzer Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Portable Bioimpedance Analyzer Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Portable Bioimpedance Analyzer Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Portable Bioimpedance Analyzer Market Dynamics
- 2.1 Portable Bioimpedance Analyzer Industry Trends
- 2.2 Portable Bioimpedance Analyzer Industry Drivers
- 2.3 Portable Bioimpedance Analyzer Industry Opportunities and Challenges
- 2.4 Portable Bioimpedance Analyzer Industry Restraints
3 Portable Bioimpedance Analyzer Market by Manufacturers
- 3.1 Global Portable Bioimpedance Analyzer Revenue by Manufacturers (2021-2026)
- 3.2 Global Portable Bioimpedance Analyzer Sales by Manufacturers (2021-2026)
- 3.3 Global Portable Bioimpedance Analyzer Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Portable Bioimpedance Analyzer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Portable Bioimpedance Analyzer Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Portable Bioimpedance Analyzer Manufacturers, Product Type & Application
- 3.7 Global Portable Bioimpedance Analyzer Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Portable Bioimpedance Analyzer Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Portable Bioimpedance Analyzer Players Market Share by Revenue in 2025
- 3.8.3 2025 Portable Bioimpedance Analyzer Tier 1, Tier 2, and Tier 3
4 Portable Bioimpedance Analyzer Market by Type
- 4.1 Portable Bioimpedance Analyzer Type Introduction
- 4.1.1 Maximum Load Capacity 150kg
- 4.1.2 Maximum Load Capacity 180kg
- 4.1.3 Maximum Load Capacity 135kg
- 4.1.4 Other
- 4.2 Global Portable Bioimpedance Analyzer Sales by Type
- 4.2.1 Global Portable Bioimpedance Analyzer Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Portable Bioimpedance Analyzer Sales by Type (2021-2032)
- 4.2.3 Global Portable Bioimpedance Analyzer Sales Market Share by Type (2021-2032)
- 4.3 Global Portable Bioimpedance Analyzer Revenue by Type
- 4.3.1 Global Portable Bioimpedance Analyzer Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Portable Bioimpedance Analyzer Revenue by Type (2021-2032)
- 4.3.3 Global Portable Bioimpedance Analyzer Revenue Market Share by Type (2021-2032)
5 Portable Bioimpedance Analyzer Market by Application
- 5.1 Portable Bioimpedance Analyzer Application Introduction
- 5.1.1 Hospital
- 5.1.2 Weight Loss Agencies
- 5.1.3 Family
- 5.1.4 Other
- 5.2 Global Portable Bioimpedance Analyzer Sales by Application
- 5.2.1 Global Portable Bioimpedance Analyzer Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Portable Bioimpedance Analyzer Sales by Application (2021-2032)
- 5.2.3 Global Portable Bioimpedance Analyzer Sales Market Share by Application (2021-2032)
- 5.3 Global Portable Bioimpedance Analyzer Revenue by Application
- 5.3.1 Global Portable Bioimpedance Analyzer Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Portable Bioimpedance Analyzer Revenue by Application (2021-2032)
- 5.3.3 Global Portable Bioimpedance Analyzer Revenue Market Share by Application (2021-2032)
6 Global Portable Bioimpedance Analyzer Sales by Region
- 6.1 Global Portable Bioimpedance Analyzer Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Portable Bioimpedance Analyzer Sales by Region (2021-2032)
- 6.2.1 Global Portable Bioimpedance Analyzer Sales by Region (2021-2026)
- 6.2.2 Global Portable Bioimpedance Analyzer Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Portable Bioimpedance Analyzer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Portable Bioimpedance Analyzer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Portable Bioimpedance Analyzer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Portable Bioimpedance Analyzer Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Portable Bioimpedance Analyzer Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Portable Bioimpedance Analyzer Revenue by Region
- 7.1 Global Portable Bioimpedance Analyzer Revenue by Region
- 7.1.1 Global Portable Bioimpedance Analyzer Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Portable Bioimpedance Analyzer Revenue by Region (2021-2026)
- 7.1.3 Global Portable Bioimpedance Analyzer Revenue by Region (2027-2032)
- 7.1.4 Global Portable Bioimpedance Analyzer Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Portable Bioimpedance Analyzer Revenue (2021-2032)
- 7.2.2 North America Portable Bioimpedance Analyzer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Portable Bioimpedance Analyzer Revenue (2021-2032)
- 7.3.2 Europe Portable Bioimpedance Analyzer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Portable Bioimpedance Analyzer Revenue (2021-2032)
- 7.4.2 Asia-Pacific Portable Bioimpedance Analyzer Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Portable Bioimpedance Analyzer Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Portable Bioimpedance Analyzer Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Emtesys
- 8.1.1 Emtesys Company Information
- 8.1.2 Emtesys Business Overview
- 8.1.3 Emtesys Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Emtesys Portable Bioimpedance Analyzer Product Portfolio
- 8.1.5 Emtesys Recent Developments
- 8.2 Omron Healthcare USA
- 8.2.1 Omron Healthcare USA Company Information
- 8.2.2 Omron Healthcare USA Business Overview
- 8.2.3 Omron Healthcare USA Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Omron Healthcare USA Portable Bioimpedance Analyzer Product Portfolio
- 8.2.5 Omron Healthcare USA Recent Developments
- 8.3 AVANUTRI
- 8.3.1 AVANUTRI Company Information
- 8.3.2 AVANUTRI Business Overview
- 8.3.3 AVANUTRI Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 AVANUTRI Portable Bioimpedance Analyzer Product Portfolio
- 8.3.5 AVANUTRI Recent Developments
- 8.4 LAICA International Corporation
- 8.4.1 LAICA International Corporation Company Information
- 8.4.2 LAICA International Corporation Business Overview
- 8.4.3 LAICA International Corporation Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 LAICA International Corporation Portable Bioimpedance Analyzer Product Portfolio
- 8.4.5 LAICA International Corporation Recent Developments
- 8.5 Tanita
- 8.5.1 Tanita Company Information
- 8.5.2 Tanita Business Overview
- 8.5.3 Tanita Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Tanita Portable Bioimpedance Analyzer Product Portfolio
- 8.5.5 Tanita Recent Developments
- 8.6 Diagnosis
- 8.6.1 Diagnosis Company Information
- 8.6.2 Diagnosis Business Overview
- 8.6.3 Diagnosis Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Diagnosis Portable Bioimpedance Analyzer Product Portfolio
- 8.6.5 Diagnosis Recent Developments
- 8.7 Terraillon
- 8.7.1 Terraillon Company Information
- 8.7.2 Terraillon Business Overview
- 8.7.3 Terraillon Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Terraillon Portable Bioimpedance Analyzer Product Portfolio
- 8.7.5 Terraillon Recent Developments
- 8.8 Withings
- 8.8.1 Withings Company Information
- 8.8.2 Withings Business Overview
- 8.8.3 Withings Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Withings Portable Bioimpedance Analyzer Product Portfolio
- 8.8.5 Withings Recent Developments
- 8.9 iHealth
- 8.9.1 iHealth Company Information
- 8.9.2 iHealth Business Overview
- 8.9.3 iHealth Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 iHealth Portable Bioimpedance Analyzer Product Portfolio
- 8.9.5 iHealth Recent Developments
- 8.10 Microlife
- 8.10.1 Microlife Company Information
- 8.10.2 Microlife Business Overview
- 8.10.3 Microlife Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Microlife Portable Bioimpedance Analyzer Product Portfolio
- 8.10.5 Microlife Recent Developments
- 8.11 Bodivis
- 8.11.1 Bodivis Company Information
- 8.11.2 Bodivis Business Overview
- 8.11.3 Bodivis Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bodivis Portable Bioimpedance Analyzer Product Portfolio
- 8.11.5 Bodivis Recent Developments
- 8.12 Fitbit
- 8.12.1 Fitbit Company Information
- 8.12.2 Fitbit Business Overview
- 8.12.3 Fitbit Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Fitbit Portable Bioimpedance Analyzer Product Portfolio
- 8.12.5 Fitbit Recent Developments
- 8.13 Medeia
- 8.13.1 Medeia Company Information
- 8.13.2 Medeia Business Overview
- 8.13.3 Medeia Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Medeia Portable Bioimpedance Analyzer Product Portfolio
- 8.13.5 Medeia Recent Developments
- 8.14 InBody
- 8.14.1 InBody Company Information
- 8.14.2 InBody Business Overview
- 8.14.3 InBody Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 InBody Portable Bioimpedance Analyzer Product Portfolio
- 8.14.5 InBody Recent Developments
- 8.15 Etekcity
- 8.15.1 Etekcity Company Information
- 8.15.2 Etekcity Business Overview
- 8.15.3 Etekcity Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Etekcity Portable Bioimpedance Analyzer Product Portfolio
- 8.15.5 Etekcity Recent Developments
- 8.16 Vitafit
- 8.16.1 Vitafit Company Information
- 8.16.2 Vitafit Business Overview
- 8.16.3 Vitafit Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Vitafit Portable Bioimpedance Analyzer Product Portfolio
- 8.16.5 Vitafit Recent Developments
- 8.17 FitTrack Dara
- 8.17.1 FitTrack Dara Company Information
- 8.17.2 FitTrack Dara Business Overview
- 8.17.3 FitTrack Dara Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 FitTrack Dara Portable Bioimpedance Analyzer Product Portfolio
- 8.17.5 FitTrack Dara Recent Developments
- 8.18 RJL Systems
- 8.18.1 RJL Systems Company Information
- 8.18.2 RJL Systems Business Overview
- 8.18.3 RJL Systems Portable Bioimpedance Analyzer Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 RJL Systems Portable Bioimpedance Analyzer Product Portfolio
- 8.18.5 RJL Systems Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Portable Bioimpedance Analyzer Value Chain Analysis
- 9.1.1 Portable Bioimpedance Analyzer Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Portable Bioimpedance Analyzer Production Mode & Process
- 9.2 Portable Bioimpedance Analyzer Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Portable Bioimpedance Analyzer Distributors
- 9.2.3 Portable Bioimpedance Analyzer Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst